Colonoscopy as a mass screening tool

European Journal of Gastroenterology and Hepatology

Volumn 10, Issue 3, 1998, Pages 225-228

  Lieberman, David ^a  

^a PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

Colonoscopy; Mass screening

Indexed keywords

CANCER MORTALITY; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; HIGH RISK PATIENT; HUMAN; MASS SCREENING; OCCULT BLOOD; PRIORITY JOURNAL; SCREENING TEST; SHORT SURVEY; SIGMOIDOSCOPY;

EID: 0031946935     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199803000-00006     Document Type: Short Survey

References (19)

1. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, • et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993; 328:1365-1371.
2. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348:1467-1471.
3. Hardcastle JD, Chamberlain J, Robinson MHE, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348:1472-1477.
4. Selby JV, Friedman GD, Quesenberry CP, Weiss NS. A case-control study • of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992; 326:653-657.
5. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992; 84:1572-1575.
6. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb L, Sternberg SS, •• et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993; 329:1977-1981.
7. Lieberman DA. Cost-effectiveness model for colon cancer screening. •• Gastroenterology 1995; 109:1781-1790.
8. Lemmel GT, Haseman JH, Rex DK, Rahmani E. Neoplasia distal to the splenic flexure in patients with proximal colon cancer. Gastrointest Endosc 1996; 44:109-111.
9. Lieberman DA, Smith FW. Screening for colon malignancy with colonoscopy. Am J Gastroenterol 1991; 86:946-951.
10. Rex DK, Lehman GA, Ulbright TM, Smith JJ, Pound DC, Hawes RH, et al. Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: influence of age, gender and family history. Am J Gastroenterol 1993; 88:825-831.
11. Foutch PG, Mai H, Pardy K, Disario JA, Manne RK, Kerr D. Flexible sigmoidoscopy may be ineffective for secondary prevention of colorectal cancer in asymptomatic average-risk men. Dig Dis Sci 1991; 36:924-928.
12. Rex DK, Cummings OW, Helper DJ, Nowak TV, McGill JM, Chiao GZ, et al. 5-year incidence of adenomas after negative colonoscopy in asymptomatic average-risk persons. Gastroenterology 1996; 111:1178-1181.
13. Anderson LM, May DS. Has the use of cervical, breast and colorectal cancer screening increased in the United States? Am J Publ Health 1995; 85:840-842.
14. Hixson LJ, Fennerty MB, Sampliner RE, Garewal HS. Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps. Gastrointest Endosc 1991; 37:125-127.
15. Rex DK, Cutler CS, Lemmel GT, Rahmani E, Clark DW, Helper DJ, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997; 112:24-28.
16. Muto T, Bussey HJR, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975; 36:2251-2270.
17. Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 1992; 326:658-662.
18. Lieberman DA. Prospective evaluation of risk factors for large (>1 cm) colonic adenomas in asymptomatic subjects. VA Cooperative Studies Program Update; 1996.
19. Wagner JL, Tunis S, Brown M, Ching A, Almeida R. Cost-effectiveness of colorectal cancer screening in average-risk adults. In:Prevention and early detection of colorectal cancer. Young GP, Rozen P, Levin B (editors). London: Saunders; 1996. pp. 321-356.